Suvro Sankha Datta: Reporting Auto-Anti-Jk Antibodies in Children with Hematological Disorders
Suvro Sankha Datta, Senior Consultant and Head Transfusion Medicine at Tata Medical Center, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Auto-anti-Jk antibodies are extremely rare in nature and can pose significant diagnostic uncertainty.
In this series, we report the presence of auto-anti-Jk in three pediatric cases with hematological disorders.
Blood group genotyping seems to be a useful way to distinguish auto- versus allo-anti-Jk antibodies.
Long-term follow-up data was used to determine the clinical behaviour of auto-Jk antibodies.”
Title: Distinguishing patients with suspected auto- versus allo-anti-Jka antibodies and highlighting the clinical significance: A case series from India
Authors: Najla Haneefa Basheela, Rashmi K. Pandey, Aniruddha Hazra, Durba Biswas, Debapriya Basu, Suvro Sankha Datta
Read the Full Article on Transfusion and Apheresis Science.
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 18, 2026, 17:48Ronak H. Mistry: Updated ASH Guidelines Bring New Focus to Iron Deficiency
-
Sep 18, 2026, 17:32Hassan Kawtharany: New Ferritin Cutoffs for the Diagnosis of Iron Deficiency With or Without Anemia
-
Sep 18, 2026, 17:20Abhishek G P: GAVE as an Important Cause of Chronic Gastrointestinal Blood Loss
-
Sep 18, 2026, 17:08Irem Karaman Sebin: ASH 2026 Changes a Key Concept in Iron Deficiency
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH